A REVIEW ARTICLE ON SAFETY DATA GENERATION

Sharuti Chaudhary*, Ajeet Thakur, Rahul, Uday Singh, Himanshu Thakur, Associate Prof. Kavita Pathania, Asst. Prof. Neha

Safety data generation is an important part of making sure medicines are safe for people. It includes collecting, studying, and understanding information about side effects and risks of drugs. This article explains how safety data is developed and how it has improved over time, along with the rules that guide it. It also describes different stages of drug development, such as laboratory testing, clinical trials on humans, and monitoring after the drug is available in the market. Important processes like Investigational New Drug (IND) and New Drug Application (NDA) are also discussed. The article highlights the role of doctors, researchers, pharmaceutical companies, and regulatory authorities in keeping medicines safe. Overall, it shows that continuous monitoring of drug safety is necessary to protect patients and improve treatment outcomes.